Latest Articles

A new study found that traumatic experiences in early life cause changes in the blood composition – namely metabolites – that are passed on to the next generation. Technology Networks spoke with Professor Isabelle Mansuy, the study leader, to find out more.

In 2020, we celebrate 90% of the human proteome being mapped by the Human Proteome Project (HPP). In this article, we reflect on the history of this endeavor and the future of the proteomics field, speaking with individuals close to the project.

EDGE’s recent neuroscience–art exhibition is a place for the “neurocurious” where science and art fuse to create something more than just art about science.

Technology Networks recently had the pleasure of speaking with Eppendorf Prize winner Christopher Zimmerman, PhD, to discover more about his research into drinking behavior.

In neuroscience research, imaging techniques are used ubiquitously to produce critical insights. Recently, sophisticated mapping, made possible by powerful elemental imaging techniques such as laser ablation (LA) in combination with inductively coupled plasma mass spectrometry (ICP-MS), has enabled studies of the distribution of different elements across an area of tissue.

Memory’s absence, amnesia, has profound implications for brain function and has been recognized as a neurological disorder for centuries. The neural underpinnings of amnesia remain a contentious and hotly debated topic. This article will examine these debates and the remaining challenges involved in understanding the neurobiological basis of amnesia.

To learn more about the PANDIS model, its aims, and how it can be used to help diagnose and treat patients suffering from a range of conditions spanning from cancers to “mystery chronic diseases”, Technology Networks spoke with PANDIS’s founders, Professor Gilles Guillemin and Catherine Stace.

An ambitious new research project powered by hitherto inaccessible techniques is investigating whether a crowded cellular environment might have a role to play in the origin of neurodegeneration.

The first widespread reports that SARS-CoV-2 might be affecting our nervous system were quite innocuous. But over the following months, reports of far more severe neurological side effects emerged. In this article, we take a look at the neurological symptoms of COVID-19.

Clinical trials are a significant milestone in the development of innovative drugs and therapies for people diagnosed with different medical conditions including multiple sclerosis (MS). In this article, we examine how technology can make it easier for people to find and enroll on clinical trials.